Epidemiology and Natural History of Non-alcoholic Fatty Liver Disease

被引:71
|
作者
Mishra, Alita [1 ]
Younossi, Zobair M. [1 ,2 ]
机构
[1] Inova Fairfax Hosp, Ctr Liver Dis, Dept Med, Falls Church, VA 22042 USA
[2] Inova Hlth Syst, Betty & Guy Beatty Ctr Integrated Res, Falls Church, VA USA
关键词
NAFLD; NASH;
D O I
10.1016/S0973-6883(12)60102-9
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Non-alcoholic fatty liver disease (NAFLD) is an important cause of liver disease burden across the world. By definition, although the histopathologic features of NAFLD are identical to that of alcoholic liver disease, its diagnosis requires absence of significant alcohol use and absence of other causes of chronic liver disease. We now know that NAFLD is not simply a disease of the Western world. It is manifested across the world, in varying rates, across gender, across varying ethnicities, and in its association with other host factors. In this review article, the definition of NAFLD, its spectrum, ranging from mild steatosis to hepatocellular injury and inflammation defined as non-alcoholic steatohepatitis (NASH) is discussed. Mild steatosis is generally a stable disease whereas NASH can be progressive. Based on current published literature, current incidence and prevalence of NAFLD and NASH are discussed. It is also accepted that these processes will continue to increase in prevalence with the rise of obesity, type II diabetes, and associated metabolic syndrome. Some of the risk factors have been well-established and are discussed. In addition, this review also presents emerging associations with other risk factors for NAFLD. Natural history of NAFLD is variable depending upon the histologic subtypes and other underlying comorbidities and is discussed in this review as well.
引用
收藏
页码:135 / 144
页数:10
相关论文
共 50 条
  • [41] Non-alcoholic fatty liver disease
    Brent A. Neuschwander-Tetri
    [J]. BMC Medicine, 15
  • [42] Non-alcoholic fatty liver disease
    Alba, LM
    Lindor, K
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (08) : 977 - 986
  • [43] Parental non-alcoholic fatty liver disease increases risk of non-alcoholic fatty liver disease in offspring
    Long, Michelle T.
    Gurary, Ellen B.
    Massaro, Joseph M.
    Ma, Jiantao
    Hoffmann, Udo
    Chung, Raymond T.
    Benjamin, Emelia J.
    Loomba, Rohit
    [J]. LIVER INTERNATIONAL, 2019, 39 (04) : 740 - 747
  • [44] Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: What we need in the future
    Araujo, Ana Ruth
    Rosso, Natalia
    Bedogni, Giorgio
    Tiribelli, Claudio
    Bellentani, Stefano
    [J]. LIVER INTERNATIONAL, 2018, 38 : 47 - 51
  • [45] Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
    Eslami, Layli
    Merat, Shahin
    Malekzadeh, Reza
    Nasseri-Moghaddam, Siavosh
    Aramin, Hermineh
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (12):
  • [46] NATURAL HISTORY OF NON-ALCOHOLIC FATTY LIVER DISEASE AMONG REAL-WORLD PATIENTS
    Nguyen, Vy H.
    Ha, Audrey
    Rouillard, Nicholas
    Le, Richard H.
    Fong, Ashley
    Gudapati, Surya T.
    Park, Jung Eun
    Maeda, Mayumi
    Barnett, Scott
    Henry, Linda
    Cheung, Ramsey
    Nguyen, Mindie H.
    [J]. GASTROENTEROLOGY, 2023, 164 (06) : S1301 - S1302
  • [47] A natural history study of paediatric non-alcoholic fatty liver disease over 10 years
    Draijer, Laura
    Voorhoeve, Maaike
    Troelstra, Marian
    Holleboom, Adriaan
    Beuers, Ulrich
    Kusters, Meeike
    Nederveen, Aart
    Benninga, Marc
    Koot, Bart
    [J]. JHEP REPORTS, 2023, 5 (05)
  • [48] Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation
    Burke, A
    Lucey, MR
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (05) : 686 - 693
  • [49] Natural compounds proposed for the management of non-alcoholic fatty liver disease
    Merenda, Theodora
    Juszczak, Florian
    Ferier, Elisabeth
    Duez, Pierre
    Patris, Stephanie
    Decleves, Anne-emilie
    Nachtergael, Amandine
    [J]. NATURAL PRODUCTS AND BIOPROSPECTING, 2024, 14 (01)
  • [50] Natural compounds proposed for the management of non-alcoholic fatty liver disease
    Théodora Merenda
    Florian Juszczak
    Elisabeth Ferier
    Pierre Duez
    Stéphanie Patris
    Anne-Émilie Declèves
    Amandine Nachtergael
    [J]. Natural Products and Bioprospecting, 2024, 14